Not only has the deal been derisked but they also have $10 million plus in the kitty for a resource upgrade drilling program and other activities in taking Rico resources forward.
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling